US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services, Genome Research, Dana Farber Cancer Institute on Aug. 25 for "Method of treating triple-negative breast cancer" (American, British Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,691, issued on Aug. 25, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.), Genome Research Ltd. (London) and Dana Farber Cancer Institute (Boston).

"Method of treating triple-negative breast cancer" was invented by William Curtis Reinhold (Rockville, Md.), Mathew Garnett (Cambridge, Great Britain), Vinodh Nalin Rajapakse (Rockville, Md.), Yves Pommier (Bethesda, Md.) and Augustin Luna (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides a method of treating triple negative breast cancer in a patient, comprising administering a the...